Perth Childrens Hospital

The trials here

What the 6 trials at this site are about, from their registry records.

Conditions

• Childhood cancers5 trials
• Acute lymphoblastic leukaemia3 trials
• Sarcoma2 trials
• Glioblastoma1 trial
• Osteoporosis1 trial

Phase

• Phase 1/23 trials
• Phase 12 trials
• Phase 31 trial

Status

• Completed2 trials
• Recruiting2 trials
• Active, not recruiting1 trial
• Terminated1 trial

Lead sponsor

• Amgen4 trials
• Takeda1 trial
• Turning Point Therapeutics, Inc.1 trial

Running trials

• Recruiting

  Evaluation of Xaluritamig in Adults, Adolescents and Children With Relapsed or Refractory Ewing Sarcoma (EWS)

  NCT07297979· Phase 1· Amgen· Source

• Active, not recruiting

  A Study of Subcutaneous Blinatumomab Administration in Participants With R/R and MRD+ B-ALL

  NCT04521231· Phase 1/2· Amgen· Source

• Recruiting

  A Study of Repotrectinib in Pediatric and Young Adult Subjects Harboring ALK, ROS1, OR NTRK1-3 Alterations

  NCT04094610· Phase 1/2· Turning Point Therapeutics, Inc.· Source

  Contact: Nick Gottardo, Site 6101

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Childhood cancers2 recruiting
• Sarcoma2 recruiting
• Glioblastoma1 recruiting

Closed trials

• Terminated

  A Study of Ponatinib With Chemotherapy in Children, Teenagers, and Adults With Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia

  NCT04501614· Phase 1/2· Takeda· Source

• Completed

  Safety and Efficiency of Denosumab in Pediatric Subjects With Glucocorticoid-induced Osteoporosis

  NCT03164928· Phase 3· Amgen· Source

• Completed

  Study of Carfilzomib in Combination With Induction Chemotherapy in Children With Relapsed or Refractory Acute Lymphoblastic Leukemia

  NCT02303821· Phase 1· Amgen· Source